Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation

OBJECTIVE: To investigate the efficacy of an injectable hydrogel loaded with lysed OK-432 (lyOK-432) and doxorubicin (DOX) for residual liver cancer after incomplete radiofrequency ablation (iRFA) of hepatocellular carcinoma (HCC), and explore the underlying mechanism. MATERIALS AND METHODS: The eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yanyan, Sun, Tao, Sun, Bo, Zhang, Guilin, Liu, Jiayun, Liang, Bin, Zheng, Chuansheng, Kan, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623833/
https://www.ncbi.nlm.nih.gov/pubmed/37919724
http://dx.doi.org/10.1186/s12951-023-02170-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623833/
https://www.ncbi.nlm.nih.gov/pubmed/37919724
http://dx.doi.org/10.1186/s12951-023-02170-0

Ejemplares similares